Answers are grounded in this paper and cite their sources.
HIF-1alpha therapy in patients with critical limb ischemia was well tolerated, supporting further, larger, randomized efficacy trials.
No takes yet. Share an insight, caveat, or question.
Rajagopalan et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: